Stem cell‐derived extracellular vesicles mitigate ageing‐associated arterial stiffness and hypertension
Open Access
- 24 June 2020
- journal article
- research article
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 9 (1) , 1783869
Abstract
The prevalence of arterial stiffness and hypertension increases with age. This study investigates the effect of induced pluripotent mesenchymal stem cell‐derived extracellular vesicles (EVs) on ageing‐associated arterial stiffness and hypertension. EVs were collected and purified from induced pluripotent stem cell‐derived mesenchymal stem cells (iPS‐MSCs). Young and old male C57BL/6 mice were used. Mice in the EVs group were injected via tail vein once a week for four weeks (18 x 10 6 EVs/mouse/injection). Blood pressure (BP) was measured using the tail‐cuff method and validated by direct cannulation. Pulse wave velocity (PWV) was measured using a Doppler workstation. PWV and BP were increased significantly in the old mice, indicating arterial stiffness and hypertension. Intravenous administration of EVs significantly attenuated ageing‐related arterial stiffness and hypertension, while enhancing endothelium‐dependent vascular relaxation and arterial compliance in the old EVs mice. Elastin degradation and collagen I deposition (fibrosis) were increased in aortas of the old mice, but EVs substantially improved ageing‐associated structural remodelling. Mechanistically, EVs abolished downregulation of sirtuin type 1 (SIRT1), and endothelial nitric oxide synthase (eNOS) protein expression in aortas of the older mice. In cultured human aortic endothelial cells, EVs promoted the expression of SIRT1, AMP‐activated protein kinase alpha (AMPKα), and eNOS. In conclusion, iPS‐MSC‐derived EVs attenuated ageing‐associated vascular endothelial dysfunction, arterial stiffness, and hypertension, likely via activation of the SIRT1‐AMPKα‐eNOS pathway and inhibition of MMPs and elastase. Thus, EVs mitigate arterial ageing. This finding also sheds light into the therapeutic potential of EVs for ageing‐related vascular diseases. Abbreviations: EV: Extracellular vesicles; iPS: induced pluripotent stem cell; MSC: mesenchymal stem cell; AMPKα: AMP activated protein kinase α; eNOS: endothelial nitric oxide synthase; Sirt1: sirtuin 1; JNC7: Seventh Report of the Joint National Committee; CVD: cardiovascular disease; PWV: pulse wave velocity; BP: blood pressure; SNP: sodium nitroprussideKeywords
Funding Information
- National Institutes of Health
- National Institutes of Health
This publication has 62 references indexed in Scilit:
- Elastin and collagen fibre microstructure of the human aorta in ageing and disease: a reviewJournal of The Royal Society Interface, 2013
- AMP Activated Protein Kinase Is Indispensable for Myocardial Adaptation to Caloric Restriction in MicePLOS ONE, 2013
- Extracellular vesicles as an emerging mechanism of cell-to-cell communicationEndocrine, 2012
- Aortic Stiffness, Blood Pressure Progression, and Incident HypertensionJAMA, 2012
- Elastin in Large Artery Stiffness and HypertensionJournal of Cardiovascular Translational Research, 2012
- Microparticles, Vascular Function, and AtherothrombosisCirculation Research, 2011
- Klotho Gene Delivery Prevents the Progression of Spontaneous Hypertension and Renal DamageHypertension, 2009
- Pulse Wave Velocity Is an Independent Predictor of the Longitudinal Increase in Systolic Blood Pressure and of Incident Hypertension in the Baltimore Longitudinal Study of AgingJACC, 2008
- Expert consensus document on arterial stiffness: methodological issues and clinical applicationsEuropean Heart Journal, 2006
- AAV delivery of mineralocorticoid receptor shRNA prevents progression of cold-induced hypertension and attenuates renal damageGene Therapy, 2006